Clinical Trials

Alliance for Clinical Trials in Oncology - Trials Studying Thyroid Cancer:

• Alliance A091302: “Randomized Phase II Study of Sorafenib With or Without Everolimus in Patients with Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer”
  • Study Chair Dr. Eric Sherman
  • Find the At-A-Glance Sheet HERE
• Alliance A091305: “Phase 2 Randomized Study Of Efatutazone, An Oral PPAR Agonist, In Combination With Paclitaxel Versus Paclitaxel In Patients With Advanced Anaplastic Thyroid Cancer”
  • Study Chair Dr. Robert Smallridge
  • Find the At-A-Glance Sheet HERE